Citations (156)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Simge Acar, Amy E. Armstrong & Angela C. Hirbe. (2022) Plexiform neurofibroma: shedding light on the investigational agents in clinical trials. Expert Opinion on Investigational Drugs 31:1, pages 31-40.
Read now
Read now
Maryam Kay, Zohreh Hojati, Maryam Heidari, Zahra Bazi & Hassan Korbekandi. (2015) Effects of disruption of the nucleotide pattern in CRID element and Kozak sequence of interferon β on mRNA stability and protein production. Autoimmunity 48:5, pages 336-343.
Read now
Read now
Parth J Parekh & Mitchell L Shiffman. (2014) The role of interferon in the new era of hepatitis C treatments. Expert Review of Gastroenterology & Hepatology 8:6, pages 649-656.
Read now
Read now
Donald C Vinh. (2014) Cytokine immunomodulation for the treatment of infectious diseases: lessons from primary immunodeficiencies. Expert Review of Clinical Immunology 10:8, pages 1069-1100.
Read now
Read now
Hana Schmeisser, Samuel B. Fey, Julie Horowitz, Elizabeth R. Fischer, Corey A. Balinsky, Kotaro Miyake, Joseph Bekisz, Andrew L. Snow & Kathryn C. Zoon. (2013) Type I interferons induce autophagy in certain human cancer cell lines. Autophagy 9:5, pages 683-696.
Read now
Read now
A.S. Bozhinov, M. Boyanova, T. Niwa, I. Ivanov & R. Mironova. (2010) Evidence for the Presence of Glycation Adducts in Protein Therapeutics. Biotechnology & Biotechnological Equipment 24:2, pages 1904-1909.
Read now
Read now
Ravinder Dhillon, Simona Rossi & Steven K Herrine. (2008) Pegylated interferon 2a and 2b in combination with ribavirin for the treatment of chronic hepatitis C in HIV infected patients. Therapeutics and Clinical Risk Management 4:4, pages 789-796.
Read now
Read now
Laura Bracci, Valentina La Sorsa, Filippo Belardelli & Enrico Proietti. (2008) Type I interferons as vaccine adjuvants against infectious diseases and cancer. Expert Review of Vaccines 7:3, pages 373-381.
Read now
Read now
. (2006) Human monoclonal antibodies to IFN-α for the treatment of autoimmune diseases. Expert Opinion on Therapeutic Patents 16:2, pages 221-226.
Read now
Read now
Articles from other publishers (147)
Abolfazl Akbari, Alireza Hadizadeh, Mahdi Amiri, Neshat Najaf Najafi, Zahra Shahriari, Tannaz Jamialahmadi & Amirhossein Sahebkar. (2023) Role of autoantibodies targeting interferon type 1 in COVID-19 severity: A systematic review and meta-analysis. Journal of Translational Autoimmunity 7, pages 100219.
Crossref
Crossref
Łukasz Suprewicz, Artur Szczepański, Marzena Lenart, Ewelina Piktel, Krzysztof Fiedoruk, Emilia Barreto-Duran, Anna Kula-Pacurar, Paul B. Savage, Aleksandra Milewska, Robert Bucki & Krzysztof Pyrć. (2023) Ceragenins exhibit antiviral activity against SARS-CoV-2 by increasing the expression and release of type I interferons upon activation of the host's immune response. Antiviral Research 217, pages 105676.
Crossref
Crossref
Ângela Cristina Malheiros Luzo, Krissia Caroline Leme, Wagner J. Fávaro, Nelson Durán, Gabriel Gaspar Bíscaro, Alexandre Leite Rodrigues de Oliveira, Karim Boumediene, Mira Hammad & Catherine Baugé. 2023. Nanotechnology and Regenerative Medicine. Nanotechnology and Regenerative Medicine
265
314
.
Ayesha Aiman, Seemi Farhat Basir & Asimul Islam. 2022. Basic and Clinical Aspects of Interferon Gamma. Basic and Clinical Aspects of Interferon Gamma.
Christopher J. Davies, Zhiqiang Fan, Kira P. Morgado, Ying Liu, Misha Regouski, Qinggang Meng, Aaron J. Thomas, Sang-Im Yun, Byung-Hak Song, Jordan C. Frank, Iuri V. Perisse, Arnaud Van Wettere, Young-Min Lee & Irina A. Polejaeva. (2022) Development and characterization of type I interferon receptor knockout sheep: A model for viral immunology and reproductive signaling. Frontiers in Genetics 13.
Crossref
Crossref
Renjing Jin, Xiaoqing Cao, Mingjun Lu, Qing Gao & Teng Ma. (2022) The intersection molecule MDA5 in Cancer and COVID-19. Frontiers in Immunology 13.
Crossref
Crossref
Jun Kyu Lee, Bo Kwon Son & Kyung Hyun Jin. (2022) A Case of Combination Therapy of IFN-β1b and Mitomycin-C on Recurred Ocular Surface Squamous Neoplasia. Journal of the Korean Ophthalmological Society 63:8, pages 712-716.
Crossref
Crossref
Maria Gómez-Herranz, Jakub Faktor, Marcos Yébenes Mayordomo, Magdalena Pilch, Marta Nekulova, Lenka Hernychova, Kathryn L. Ball, Borivoj Vojtesek, Ted R. Hupp & Sachin Kote. (2022) Emergent Role of IFITM1/3 towards Splicing Factor (SRSF1) and Antigen-Presenting Molecule (HLA-B) in Cervical Cancer. Biomolecules 12:8, pages 1090.
Crossref
Crossref
Lorenza A. D’Alessandro, Ursula Klingmüller & Marcel Schilling. (2022) Deciphering signal transduction networks in the liver by mechanistic mathematical modelling. Biochemical Journal 479:12, pages 1361-1374.
Crossref
Crossref
Weiye Shi, Xu Yao, Yu Fu & Yingze Wang. (2022) Interferon‑α and its effects on cancer cell apoptosis (Review). Oncology Letters 24:1.
Crossref
Crossref
Bratko Filipič, Lidija Gradišnik, Adriana Pereyra, Gordan Mršić, Marjan Andrašec & Hrvoje Mazija. (2022) The Enhancing Effects of 10% PBS Washout of Holocene Minerals on HuIFN-αN3 Inducing Capacity of NDV ZG1999HDS or Sendai virus (Cantell Strain). Life 12:3, pages 414.
Crossref
Crossref
Sofía Inés Giorgetti, Marina Etcheverrigaray, Frances Terry, William Martin, Anne Searls De Groot, Natalia Ceaglio, Marcos Oggero & Eduardo Federico Mufarrege. (2021) Development of highly stable and de-immunized versions of recombinant alpha interferon: Promising candidates for the treatment of chronic and emerging viral diseases. Clinical Immunology 233, pages 108888.
Crossref
Crossref
Erika Hay-McCullough & Juliet Morrison. (2021) Contributions of Ubiquitin and Ubiquitination to Flaviviral Antagonism of Type I IFN. Viruses 13:5, pages 763.
Crossref
Crossref
Nadège NéantGuillaume Lingas, Quentin Le Hingrat, Jade GhosnIlka EngelmannQuentin LepillerAlexandre Gaymard, Virginie Ferré, Cédric Hartard, Jean-Christophe PlantierVincent ThibaultJulien MarletBrigitte Montes, Kevin BouillerFrançois-Xavier LescureJean-François Timsit, Emmanuel FaureJulien PoissyChristian Chidiac, François RaffiAntoine Kimmoun, Manuel Etienne, Jean-Christophe Richard, Pierre Tattevin, Denis Garot, Vincent Le MoingDelphine Bachelet, Coralie TardivonXavier Duval, Yazdan YazdanpanahFrance Mentré, Cédric Laouénan, Benoit Visseaux & Jérémie Guedj. (2021) Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort. Proceedings of the National Academy of Sciences 118:8.
Crossref
Crossref
Natascha Gödecke, Jan Riedel, Sabrina Herrmann, Sara Behme, Ulfert Rand, Tobias Kubsch, Luka Cicin-Sain, Hansjörg Hauser, Mario Köster & Dagmar Wirth. (2020) Synthetic rewiring and boosting type I interferon responses for visualization and counteracting viral infections. Nucleic Acids Research 48:20, pages 11799-11811.
Crossref
Crossref
Nancy Patricia Cardoso, Florencia Celeste Mansilla, Estefanía Benedetti, Cecilia Soledad Turco, Lucas José Barone, Javier Alonso Iserte, Ivana Soria, Elsa Baumeister & Alejandra Victoria Capozzo. (2020) Bovine Interferon Lambda Is a Potent Antiviral Against SARS-CoV-2 Infection in vitro. Frontiers in Veterinary Science 7.
Crossref
Crossref
Vincent Madelain, France Mentré, Sylvain Baize, Xavier Anglaret, Cédric Laouénan, Lisa Oestereich, Thi Huyen Tram Nguyen, Denis Malvy, Géraldine Piorkowski, Frederik Graw, Stephan Günther, Hervé Raoul, Xavier Lamballerie & Jérémie Guedj. (2020) Modeling Favipiravir Antiviral Efficacy Against Emerging Viruses: From Animal Studies to Clinical Trials. CPT: Pharmacometrics & Systems Pharmacology.
Crossref
Crossref
Renée M. Van der Sluis, Jennifer M. Zerbato, Jake W. Rhodes, Rachel D. Pascoe, Ajantha Solomon, Nitasha A. Kumar, Ashanti I. Dantanarayana, Surekha Tennakoon, Jérémy Dufloo, James McMahon, Judy J. Chang, Vanessa A. Evans, Paul J. Hertzog, Martin R. Jakobsen, Andrew N. Harman, Sharon R. Lewin & Paul U. Cameron. (2020) Diverse effects of interferon alpha on the establishment and reversal of HIV latency. PLOS Pathogens 16:2, pages e1008151.
Crossref
Crossref
Natalie Winblade Nairn, Kenneth Grabstein, Kurt D. Shanebeck, Gary Li & Aijun Wang. 2020. Polymer-Protein Conjugates. Polymer-Protein Conjugates
317
349
.
Carolina Attallah, María C Rodríguez, Victoria Lozano, Marina Etcheverrigaray & Marcos Oggero. (2019) Design and validation of an immuno-PCR assay for IFN-α2b quantification in human plasma. Bioanalysis 11:23, pages 2175-2188.
Crossref
Crossref
Peter D. Burbelo, Sarah Browne, Steve M. Holland, Michael J. Iadarola & Ilias Alevizos. (2019) Clinical features of Sjögren's syndrome patients with autoantibodies against interferons. Clinical and Translational Medicine 8:1.
Crossref
Crossref
Swati Bandi, Surinder M. Singh, Dinen D. Shah, Vaibhav Upadhyay & Krishna M.G. Mallela. (2019) 2D NMR Analysis of the Effect of Asparagine Deamidation Versus Methionine Oxidation on the Structure, Stability, Aggregation, and Function of a Therapeutic Protein. Molecular Pharmaceutics 16:11, pages 4621-4635.
Crossref
Crossref
Maria Gómez-Herranz, Marta Nekulova, Jakub Faktor, Lenka Hernychova, Sachin Kote, Elizabeth H. Sinclair, Rudolf Nenutil, Borivoj Vojtesek, Kathryn L. Ball & Ted R. Hupp. (2019) The effects of IFITM1 and IFITM3 gene deletion on IFNγ stimulated protein synthesis. Cellular Signalling 60, pages 39-56.
Crossref
Crossref
Hua ZhaoNan DongTing LiuPeng ZhangYawen ZhengLili YangXiubao Ren. (2019) Clinical Significance of Serum Type III Interferons in Patients with Gastric Cancer. Journal of Interferon & Cytokine Research 39:3, pages 155-163.
Crossref
Crossref
Hailong Ma, Wenyi Yang, Liming Zhang, Shuli Liu, Mei Zhao, Ge Zhou, Lizhen Wang, Shufang Jin, Zhiyuan Zhang & Jingzhou Hu. (2018) Interferon-alpha promotes immunosuppression through IFNAR1/STAT1 signalling in head and neck squamous cell carcinoma. British Journal of Cancer 120:3, pages 317-330.
Crossref
Crossref
Shilpa Kodati & Christina Y. Weng. (2019) Current and Emerging Pharmaceutical Therapies for Noninfectious Uveitis. International Ophthalmology Clinics 59:1, pages 111-126.
Crossref
Crossref
Dinen D. Shah, Surinder M. Singh & Krishna M. G. Mallela. (2018) Effect of Chemical Oxidation on the Higher Order Structure, Stability, Aggregation, and Biological Function of Interferon Alpha-2a: Role of Local Structural Changes Detected by 2D NMR. Pharmaceutical Research 35:12.
Crossref
Crossref
Vincent Madelain, Sylvain Baize, Frédéric Jacquot, Stéphanie Reynard, Alexandra Fizet, Stephane Barron, Caroline Solas, Bruno Lacarelle, Caroline Carbonnelle, France Mentré, Hervé Raoul, Xavier de Lamballerie & Jérémie Guedj. (2018) Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies. Nature Communications 9:1.
Crossref
Crossref
Christopher Goodwin, Jessica Ciesla & Joshua Munger. (2018) Who’s Driving? Human Cytomegalovirus, Interferon, and NFκB Signaling. Viruses 10:9, pages 447.
Crossref
Crossref
Guangyun Tan, Hongxiao Song, Fengchao Xu & Genhong Cheng. (2018) When Hepatitis B Virus Meets Interferons. Frontiers in Microbiology 9.
Crossref
Crossref
Lijie Gao, Yunqi Wang, Yi Li, Ya Dong, Aimin Yang, Jie Zhang, Fengying Li & Rongqiang Zhang. (2018)
Genome-wide expression profiling analysis to identify key genes in the anti-HIV mechanism of CD4
+
and CD8
+
T cells
. Journal of Medical Virology 90:7, pages 1199-1209.
Crossref
Crossref
Sakshi Khosa, Romy Scholz, Christian Schwarz, Mirko Trilling, Hartmut Hengel, Karl-Erich Jaeger, Sander H. J. Smits & Lutz Schmitt. (2018) An A/U-Rich Enhancer Region Is Required for High-Level Protein Secretion through the HlyA Type I Secretion System. Applied and Environmental Microbiology 84:1.
Crossref
Crossref
Hao Chen, Xiao Zheng, Justine Nicholas, Sara T. Humes, Julia C. Loeb, Sarah E. Robinson, Joseph H. BisesiJrJr, Dipesh Das, Navid B. Saleh, William L. Castleman, John A. Lednicky & Tara Sabo-Attwood. (2017) Single-walled carbon nanotubes modulate pulmonary immune responses and increase pandemic influenza a virus titers in mice. Virology Journal 14:1.
Crossref
Crossref
Yanpeng LiBinlian SunStefan EsserHeiko JessenHendrik StreeckMarek WideraRongge YangUlf DittmerKathrin Sutter. (2017)
Expression Pattern of Individual
IFNA
Subtypes in Chronic HIV Infection
. Journal of Interferon & Cytokine Research 37:12, pages 541-549.
Crossref
Crossref
Shi-fang Li, Fu-rong Zhao, Jun-jun Shao, Yin-li Xie, Hui-yun Chang & Yong-guang Zhang. (2017) Interferon-omega: Current status in clinical applications. International Immunopharmacology 52, pages 253-260.
Crossref
Crossref
Asona J. Lui, Eric S. Geanes, Joshua Ogony, Fariba Behbod, Jordan Marquess, Kelli Valdez, William Jewell, Ossama Tawfik & Joan Lewis-Wambi. (2017) IFITM1 suppression blocks proliferation and invasion of aromatase inhibitor-resistant breast cancer in vivo by JAK/STAT-mediated induction of p21. Cancer Letters 399, pages 29-43.
Crossref
Crossref
Valeria Cento, Thi Huyen Tram Nguyen, Domenico Di Carlo, Elisa Biliotti, Laura Gianserra, Ilaria Lenci, Daniele Di Paolo, Vincenza Calvaruso, Elisabetta Teti, Maddalena Cerrone, Dante Romagnoli, Michela Melis, Elena Danieli, Barbara Menzaghi, Ennio Polilli, Massimo Siciliano, Laura Ambra Nicolini, Antonio Di Biagio, Carlo Federico Magni, Matteo Bolis, Francesco Paolo Antonucci, Velia Chiara Di Maio, Roberta Alfieri, Loredana Sarmati, Paolo Casalino, Sergio Bernardini, Valeria Micheli, Giuliano Rizzardini, Giustino Parruti, Tiziana Quirino, Massimo Puoti, Sergio Babudieri, Antonella D’Arminio Monforte, Massimo Andreoni, Antonio Craxì, Mario Angelico, Caterina Pasquazzi, Gloria Taliani, Jeremie Guedj, Carlo Federico Perno & Francesca Ceccherini-Silberstein. (2017) Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens. PLOS ONE 12:5, pages e0177352.
Crossref
Crossref
. (2017) Retraction notice. Muscle & Nerve 55:5, pages 766-766.
Crossref
Crossref
W.M.S. Degrave & L. Mendonça-Lima. 2017. Current Developments in Biotechnology and Bioengineering. Current Developments in Biotechnology and Bioengineering
51
70
.
Regina I. Jakacki, Eva Dombi, Seth M. Steinberg, Stewart Goldman, Mark W. Kieran, Nicole J. Ullrich, Ian F. Pollack, Anne Goodwin, Peter E. Manley, Jason Fangusaro, Rudy Allen & Brigitte C. Widemann. (2016) Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromas. Neuro-Oncology, pages now158.
Crossref
Crossref
Yen H. Pham & Philip Rosenthal. (2016) Chronic Hepatitis C Infection in Children. Advances in Pediatrics 63:1, pages 173-194.
Crossref
Crossref
Vincent Madelain, Thi Huyen Tram Nguyen, Anaelle Olivo, Xavier de Lamballerie, Jérémie Guedj, Anne-Marie Taburet & France Mentré. (2016) Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials. Clinical Pharmacokinetics 55:8, pages 907-923.
Crossref
Crossref
Sean G Smith & David A Zaharoff. (2016) Future directions in bladder cancer immunotherapy: towards adaptive immunity. Immunotherapy 8:3, pages 351-365.
Crossref
Crossref
Maryam Kay, Amin Moradi Hasan-Abad, Zohreh Hojati & Hasan Korbekandi. (2016) Targeted mutations in Val101 and Arg27 interferon beta protein increase its transcriptional and translational activities. Cytokine 78, pages 1-6.
Crossref
Crossref
Gerson Dierley Keppeke. (2016) Anti-rods/rings autoantibody generation in hepatitis C patients during interferon-α/ribavirin therapy. World Journal of Gastroenterology 22:6, pages 1966.
Crossref
Crossref
E. Kindler, V. Thiel & F. Weber. 2016. Coronaviruses. Coronaviruses
219
243
.
N. Dafny & J. Lincoln. 2016. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Sarfaraz Niazi. 2015. Biosimilars and Interchangeable Biologics. Biosimilars and Interchangeable Biologics
23
66
.
Jared J. Romero, Alfredo Q. Antoniazzi, Terry M. Nett, Ryan L. Ashley, Brett T. Webb, Natalia P. Smirnova, Rebecca C. Bott, Jason E. Bruemmer, Fuller W. Bazer, Russell V. Anthony & Thomas R. Hansen. (2015) Temporal Release, Paracrine and Endocrine Actions of Ovine Conceptus-Derived Interferon-Tau During Early Pregnancy1. Biology of Reproduction 93:6.
Crossref
Crossref
Run TongLin FengLei ZhangJianzhi ZhangYousheng MaoKaitai ZhangYanning GaoGuiqi WangShujun Cheng. (2015) Decreased Interferon Alpha/Beta Signature Associated with Human Lung Tumorigenesis. Journal of Interferon & Cytokine Research 35:12, pages 963-968.
Crossref
Crossref
Natalie W. Nairn, Pauline A. Bariola, Thomas J. Graddis, Michael Pete VanBrunt, Aijun Wang, Gary Li & Kenneth Grabstein. (2015) Cysteine as a Monothiol Reducing Agent to Prevent Copper-Mediated Oxidation of Interferon Beta During PEGylation by CuAAC. Bioconjugate Chemistry 26:10, pages 2070-2075.
Crossref
Crossref
Antonio Bertolotto. (2015) Evaluation of the impact of neutralizing antibodies on IFNβ response. Clinica Chimica Acta 449, pages 31-36.
Crossref
Crossref
Cansu YıldırımSylvia NieuwenhuisPaul F. TeunissenAnton J.G. HorrevoetsNiels van RoyenTineke C.T.M. van der Pouw Kraan. (2015) Interferon-Beta, a Decisive Factor in Angiogenesis and Arteriogenesis. Journal of Interferon & Cytokine Research 35:6, pages 411-420.
Crossref
Crossref
Stephanie BooyLeo HoflandCasper van Eijck. (2015) Potentials of Interferon Therapy in the Treatment of Pancreatic Cancer. Journal of Interferon & Cytokine Research 35:5, pages 327-339.
Crossref
Crossref
A. Bertolotto, L. Granieri, F. Marnetto, P. Valentino, A. Sala, M. Capobianco, S. Malucchi, A. Di Sapio, M. Malentacchi, M. Matta & M. Caldano. (2015) Biological monitoring of IFN-β therapy in Multiple Sclerosis. Cytokine & Growth Factor Reviews 26:2, pages 241-248.
Crossref
Crossref
Mojtaba Samoudi, Fatemeh Tabandeh, Zarrin Minuchehr, Reza Ahangari Cohan, Davoud Nouri Inanlou, Mahvash Khodabandeh & Mohammad Sabery Anvar. (2015) Rational design of hyper-glycosylated interferon beta analogs: A computational strategy for glycoengineering. Journal of Molecular Graphics and Modelling 56, pages 31-42.
Crossref
Crossref
Tiina Lipiäinen, Marikki Peltoniemi, Sanjay Sarkhel, Teijo Yrjönen, Heikki Vuorela, Arto Urtti & Anne Juppo. (2015) Formulation and Stability of Cytokine Therapeutics. Journal of Pharmaceutical Sciences 104:2, pages 307-326.
Crossref
Crossref
Stephanie Booy, Leo J. Hofland, A. Marlijn Waaijers, Ed Croze, Peter M. van Koetsveld, Lisette de Vogel, Katharina Biermann & Casper H.J. van Eijck. (2015) Type I Interferon Receptor Expression in Human Pancreatic and Periampullary Cancer Tissue. Pancreas 44:1, pages 99-105.
Crossref
Crossref
Kanika Kanchan, Pankaj Jha, Sudhanshu S. Pati, Sanjib Mohanty, Saroj K. Mishra, Surya K. Sharma, Shally Awasthi, Vimala Venkatesh & Saman Habib. (2015) Interferon-γ (IFNG) microsatellite repeat and single nucleotide polymorphism haplotypes of IFN-α receptor (IFNAR1) associated with enhanced malaria susceptibility in Indian populations. Infection, Genetics and Evolution 29, pages 6-14.
Crossref
Crossref
Ernest C. Borden. 2015. The Molecular Basis of Cancer. The Molecular Basis of Cancer
739
752.e7
.
Zlatko Dembic. 2015. The Cytokines of the Immune System. The Cytokines of the Immune System
123
142
.
Mayer Fishman. 2015. Renal Cell Carcinoma. Renal Cell Carcinoma
441
467
.
Li Ma, Yun Zhou, Ying Zhang, Yuan Li, Yonghong Guo, Yu He, Jiuping Wang, Jianqi Lian, Chunqiu Hao, Jonathan P. Moorman, Zhi Q. Yao, Yongxing Zhou & Zhansheng Jia. (2014)
Role of A20 in interferon-
α
-mediated functional restoration of myeloid dendritic cells in patients with chronic hepatitis C
. Immunology 143:4, pages 670-678.
Crossref
Crossref
Haitham Mirghani, Nicolas Ugolin, Catherine Ory, Marine Lefèvre, Sylvain Baulande, Paul Hofman, Jean Lacau St Guily, Sylvie Chevillard & Roger Lacave. (2014) A predictive transcriptomic signature of oropharyngeal cancer according to HPV16 status exclusively. Oral Oncology 50:11, pages 1025-1034.
Crossref
Crossref
Weili Yu, Changming Yu, Ling Wu, Ting Fang, Rui Qiu, Jinlong Zhang, Ting Yu, Ling Fu, Wei Chen & Tao Hu. (2014) PEGylated recombinant human interferon-ω as a long-acting antiviral agent: Structure, antiviral activity and pharmacokinetics. Antiviral Research 108, pages 142-147.
Crossref
Crossref
Regina L. Bis, Tara M. Stauffer, Surinder M. Singh, Thomas B. Lavoie & Krishna M.G. Mallela. (2014) High yield soluble bacterial expression and streamlined purification of recombinant human interferon α-2a. Protein Expression and Purification 99, pages 138-146.
Crossref
Crossref
Karolina Peciak, Rita Tommasi, Ji-won Choi, Steve Brocchini & Emmanuelle Laurine. (2014) Expression of soluble and active interferon consensus in SUMO fusion expression system in E. coli. Protein Expression and Purification 99, pages 18-26.
Crossref
Crossref
HyeonJoo Cheon, Ernest C. Borden & George R. Stark. (2014) Interferons and Their Stimulated Genes in the Tumor Microenvironment. Seminars in Oncology 41:2, pages 156-173.
Crossref
Crossref
Stephanie Booy, Casper H. J. Eijck, Fadime Dogan, Peter M. Koetsveld & Leo J. Hofland. (2014) Influence of type‐I Interferon receptor expression level on the response to type‐I Interferons in human pancreatic cancer cells. Journal of Cellular and Molecular Medicine 18:3, pages 492-502.
Crossref
Crossref
Junfeng Wang, Changting Liu, Jinyi Liu, Xiangqun Fang, Chen Xu, Yinghua Guo, De Chang & Longxiang Su. (2013) Space mutagenesis of genetically engineered bacteria expressing recombinant human interferon α1b and screening of higher yielding strains. World Journal of Microbiology and Biotechnology 30:3, pages 943-949.
Crossref
Crossref
Rodney J. Y. Ho & Milo Gibaldi. 2013. Biotechnology and Biopharmaceuticals. Biotechnology and Biopharmaceuticals
251
305
.
Amir Hossein Taromchi, Bahram Kazemi, Sanaz Mahmazi & Mojgan Bandehpour. (2013) Heterologous Expression of Human IL-29 (IFN-λ1) in Iranian Lizard Leishmania. Iranian Journal of Biotechnology 11:3, pages 168-74.
Crossref
Crossref
Liang-Tzung Lin, Ting-Ying Chen, Song-Chow Lin, Chueh-Yao Chung, Ta-Chen Lin, Guey-Horng Wang, Robert Anderson, Chun-Ching Lin & Christopher D Richardson. (2013) Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry. BMC Microbiology 13:1, pages 187.
Crossref
Crossref
Adriano Boasso. (2013) Type I Interferon at the Interface of Antiviral Immunity and Immune Regulation: The Curious Case of HIV-1. Scientifica 2013, pages 1-20.
Crossref
Crossref
WonHyung Choi & JongPhil Chu. (2012) The characteristics of the expression of heat shock proteins and cox-2 in the liver of hamsters infected with Clonorchis sinensis, and the change of endocrine hormones and cytokines. Folia Parasitologica 59:4, pages 255-263.
Crossref
Crossref
Vinod H. Nargund, C.K. Tanabalan & M.N. Kabir. (2012) Management of Non–Muscle-Invasive (Superficial) Bladder Cancer. Seminars in Oncology 39:5, pages 559-572.
Crossref
Crossref
Roland E. Kontermann. (2012) Antibody–cytokine fusion proteins. Archives of Biochemistry and Biophysics 526:2, pages 194-205.
Crossref
Crossref
Marta Catalfamo, Cecile Le Saout & H. Clifford Lane. (2012) The role of cytokines in the pathogenesis and treatment of HIV infection. Cytokine & Growth Factor Reviews 23:4-5, pages 207-214.
Crossref
Crossref
Prakasha Kempaiah, Samuel B. Anyona, Evans Raballah, Gregory C. Davenport, Tom Were, James B. Hittner, John M. Ong’echa & Douglas J. Perkins. (2012) Reduced interferon (IFN)-α conditioned by IFNA2 (−173) and IFNA8 (−884) haplotypes is associated with enhanced susceptibility to severe malarial anemia and longitudinal all-cause mortality. Human Genetics 131:8, pages 1375-1391.
Crossref
Crossref
Adam J. Karpala, John W. Lowenthal & Andrew G.D. Bean. (2012) Identifying innate immune pathways of the chicken may lead to new antiviral therapies. Veterinary Immunology and Immunopathology 148:1-2, pages 100-109.
Crossref
Crossref
Hideyuki Nakashima, Kotaro Miyake, Christopher R. Clark, Joseph Bekisz, Joel Finbloom, Syed R. Husain, Samuel Baron, Raj K. Puri & Kathryn C. Zoon. (2011) Potent antitumor effects of combination therapy with IFNs and monocytes in mouse models of established human ovarian and melanoma tumors. Cancer Immunology, Immunotherapy 61:7, pages 1081-1092.
Crossref
Crossref
Cara L. Mack, Regino P. Gonzalez-Peralta, Nitika Gupta, Daniel Leung, Michael R. Narkewicz, Eve A. Roberts, Philip Rosenthal & Kathleen B. Schwarz. (2012) NASPGHAN Practice Guidelines. Journal of Pediatric Gastroenterology & Nutrition 54:6, pages 838-855.
Crossref
Crossref
Cruz Reyes-Vázquez, Bertha Prieto-Gómez & Nachum Dafny. (2012) Interferon modulates central nervous system function. Brain Research 1442, pages 76-89.
Crossref
Crossref
Masayoshi Yamasaki, Katsuhisa Matsumoto, Yu Takahashi, Hirotaka Nakanishi, Yoshinari Kawai & Masanori Miyamura. (2012) A case of NMO (neuromyelitis optica) spectum disorder triggered by interferon alpha, which involved extensive pyramidal tract lesion of the brain. Rinsho Shinkeigaku 52:1, pages 19-24.
Crossref
Crossref
Wilbert A. Derbigny, LaTasha R. Shobe, Jasmine C. Kamran, Katherine S. Toomey & Susan Ofner. (2012) Identifying a Role for Toll-Like Receptor 3 in the Innate Immune Response to Chlamydia muridarum Infection in Murine Oviduct Epithelial Cells. Infection and Immunity 80:1, pages 254-265.
Crossref
Crossref
Natalia Ceaglio, Marina Etcheverrigaray, Ricardo Kratje, Harald S. Conradt & Marcos Oggero. 2012. Proceedings of the 21st Annual Meeting of the European Society for Animal Cell Technology (ESACT), Dublin, Ireland, June 7-10, 2009. Proceedings of the 21st Annual Meeting of the European Society for Animal Cell Technology (ESACT), Dublin, Ireland, June 7-10, 2009
535
555
.
Andrew Aronsohn & Donald Jensen. 2012. Chronic Hepatitis C Virus. Chronic Hepatitis C Virus
271
277
.
Yiming Li, Walter F. Stafford, Mark Hesselberg, David Hayes, Zhuchun Wu & Michael Byrne. (2012) Characterization of the Self-Association of Human Interferon-α2b, Albinterferon-α2b, and Pegasys. Journal of Pharmaceutical Sciences 101:1, pages 68-80.
Crossref
Crossref
Céline Robert-Tissot, Vera L. Rüegger, Valentino Cattori, Marina L. Meli, Barbara Riond, Maria Alice Gomes-Keller, Andrea Vögtlin, Burghardt Wittig, Christiane Juhls, Regina Hofmann-Lehmann & Hans Lutz. (2011) The innate antiviral immune system of the cat: Molecular tools for the measurement of its state of activation. Veterinary Immunology and Immunopathology 143:3-4, pages 269-281.
Crossref
Crossref
Samuel BaronJoel FinbloomJulie HorowitzJoseph BekiszAngel MorrowTongmao ZhaoSamuel FeyHana SchmeisserCorey BalinskyKotaro MiyakeChristopher ClarkKathryn Zoon. (2011)
Near Eradication of Clinically Relevant Concentrations of Human Tumor Cells by Interferon-Activated Monocytes
In Vitro
. Journal of Interferon & Cytokine Research 31:7, pages 569-573.
Crossref
Crossref
Weiye Chen, Wenyan Cao, Huijun Zhao, Qianqian Hu, Linmao Qu, Sen Hu, Jinying Ge, Zhiyuan Wen, Xijun Wang, HaoBo Li, Kehe Huang & Zhigao Bu. (2011) Establishment of a stable CHO cell line with high level expression of recombinant porcine IFN-β. Cytokine 54:3, pages 324-329.
Crossref
Crossref
Naohisa WadaPeter Mark BartoldStan Gronthos. (2011) Human Foreskin Fibroblasts Exert Immunomodulatory Properties by a Different Mechanism to Bone Marrow Stromal/Stem Cells. Stem Cells and Development 20:4, pages 647-659.
Crossref
Crossref
Theo Dingermann & Ilse Zündorf. (2010) Alfa‐Interferone. Gentechnisch hergestellte Virustatika. Pharmazie in unserer Zeit 40:1, pages 68-77.
Crossref
Crossref
Wilbert A. Derbigny, Raymond M. Johnson, Katherine S. Toomey, Susan Ofner & Krupakar Jayarapu. (2010)
The
Chlamydia muridarum
-Induced IFN-β Response Is TLR3-Dependent in Murine Oviduct Epithelial Cells
. The Journal of Immunology 185:11, pages 6689-6697.
Crossref
Crossref
Jarosław Śmieja. (2010) Coupled analytical and numerical approach to uncovering new regulatory mechanisms of intracellular processes. International Journal of Applied Mathematics and Computer Science 20:4, pages 781-788.
Crossref
Crossref
Alexander Zdanov. (2010) Structural analysis of cytokines comprising the IL-10 family. Cytokine & Growth Factor Reviews 21:5, pages 325-330.
Crossref
Crossref
Guimei He, Beibei He, Paul A. Racey & Jie Cui. (2010) Positive Selection of the Bat Interferon Alpha Gene Family. Biochemical Genetics 48:9-10, pages 840-846.
Crossref
Crossref
Chanunta Hongthanakorn & Anna S.F. Lok. (2010) New Pharmacologic Therapies in Chronic Hepatitis B. Gastroenterology Clinics of North America 39:3, pages 659-680.
Crossref
Crossref
Xiufen Zou, Xueshuang Xiang, Yan Chen, Tao Peng, Xuelian Luo & Zishu Pan. (2010) Understanding inhibition of viral proteins on type I IFN signaling pathways with modeling and optimization. Journal of Theoretical Biology 265:4, pages 691-703.
Crossref
Crossref
Natalia Ceaglio, Marina Etcheverrigaray, Ricardo Kratje & Marcos Oggero. (2010) Influence of carbohydrates on the stability and structure of a hyperglycosylated human interferon alpha mutein. Biochimie 92:8, pages 971-978.
Crossref
Crossref
Aaron Farnsworth, Anathea S. Flaman, Shiv S. Prasad, Caroline Gravel, Andrew Williams, Carole L. Yauk & Xuguang Li. (2010) Acetaminophen Modulates the Transcriptional Response to Recombinant Interferon-β. PLoS ONE 5:6, pages e11031.
Crossref
Crossref
Robert Herok, Maria Konopacka, Joanna Polanska, Andrzej Swierniak, Jacek Rogolinski, Roman Jaksik, Ronald Hancock & Joanna Rzeszowska-Wolny. (2010) Bystander Effects Induced by Medium From Irradiated Cells: Similar Transcriptome Responses in Irradiated and Bystander K562 Cells. International Journal of Radiation Oncology*Biology*Physics 77:1, pages 244-252.
Crossref
Crossref
Leonid Kagan, Anson K. Abraham, John M. Harrold & Donald E. Mager. (2010) Interspecies Scaling of Receptor-Mediated Pharmacokinetics and Pharmacodynamics of Type I Interferons. Pharmaceutical Research 27:5, pages 920-932.
Crossref
Crossref
Roberto G. Pozner, Agustín E. Ure, Carolina Jaquenod de Giusti, Lina P. D'Atri, Joseph E. Italiano, Oscar Torres, Victor Romanowski, Mirta Schattner & Ricardo M. Gómez. (2010) Junín Virus Infection of Human Hematopoietic Progenitors Impairs In Vitro Proplatelet Formation and Platelet Release via a Bystander Effect Involving Type I IFN Signaling. PLoS Pathogens 6:4, pages e1000847.
Crossref
Crossref
Renaud ColissonLucie BarbluChristophe GrasFrançoise Raynaud, Reda Hadj-Slimane, Claudine Pique, Olivier HermineYves LepelletierJean-Philippe Herbeuval. (2010) Free HTLV-1 induces TLR7-dependent innate immune response and TRAIL relocalization in killer plasmacytoid dendritic cells. Blood 115:11, pages 2177-2185.
Crossref
Crossref
Kotaro Miyake, Satoru Imura, Masanori Nishioka, Erdenebulgan Batmunkh, Koji Sugimoto, Yasukazu Ohmoto & Mitsuo Shimada. (2010) Serum evaluation of soluble interferon-α/β receptor and high-sensitivity C-reactive protein for diagnosis of the patients with gastrointestinal and hepatobiliary-pancreatic cancer. Cytokine 49:3, pages 251-255.
Crossref
Crossref
Mike C. WolfAlexander N. FreibergTinghu ZhangZeynep Akyol-AtamanAndrew GrockPatrick W. HongJianrong LiNatalya F. WatsonAngela Q. FangHector C. AguilarMatteo Porotto, Anna N. HonkoRobert DamoiseauxJohn P. MillerSara E. WoodsonSteven ChantasirivisalVanessa FontanesOscar A. NegretePaul KrogstadAsim DasguptaAnne Moscona, Lisa E. HensleySean P. WhelanKym F. FaullMichael R. HolbrookMichael E. JungBenhur Lee. (2010) A broad-spectrum antiviral targeting entry of enveloped viruses. Proceedings of the National Academy of Sciences 107:7, pages 3157-3162.
Crossref
Crossref
V. Caracciolo & A. Giordano. 2010. Comprehensive Toxicology. Comprehensive Toxicology
1
13
.
Esperanza Gómez-Lucía, Victorio M. Collado, Guadalupe Miró & Ana Doménech. (2009) Effect of Type-I Interferon on Retroviruses. Viruses 1:3, pages 545-573.
Crossref
Crossref
Giovanni Vitale, Michele Caraglia, Peter M. van Koetsveld, Paola Maroni, Monica Marra, Annamaria Colao, Steven W. J. Lamberts, Francesco Cavagnini & Leo J. Hofland. (2008) Potential role of type I interferons in the treatment of pituitary adenomas. Reviews in Endocrine and Metabolic Disorders 10:2, pages 125-133.
Crossref
Crossref
Vito R. CicinnatiJinyu KangJing HouMonika LindemannKarsten KoopThomas TütingGuido GerkenSusanne Beckebaum. (2009) Interferon-α Differentially Affects Homeostasis of Human Plasmacytoid and Myeloid Dendritic Cells. Journal of Interferon & Cytokine Research 29:3, pages 145-160.
Crossref
Crossref
Young Mok Kim, Hye Ja Lee, Jung Eun Lee, Hae Yeong Kim & Jongsun Kim. (2009) Expression of human interferon α-1 with enhanced stability via the tagging system of a stabilizing peptide. Protein Expression and Purification 63:2, pages 140-146.
Crossref
Crossref
Jarosław śmieja. (2009) Advantages and pitfalls of mathematical modelling used for validation of biological hypotheses. IFAC Proceedings Volumes 42:12, pages 348-353.
Crossref
Crossref
Steven K. Herrine, Simona Rossi & Victor J. Navarro. 2009. Pharmacology and Therapeutics. Pharmacology and Therapeutics
527
547
.
Jarosław Smieja. 2009. Bioinformatics and Computational Biology. Bioinformatics and Computational Biology
400
408
.
Matthew Frieman & Ralph Baric. (2008) Mechanisms of Severe Acute Respiratory Syndrome Pathogenesis and Innate Immunomodulation. Microbiology and Molecular Biology Reviews 72:4, pages 672-685.
Crossref
Crossref
Jaroslaw Smieja, Mohammad Jamaluddin, Allan R. Brasier & Marek Kimmel. (2008) Model-based analysis of interferon-β induced signaling pathway. Bioinformatics 24:20, pages 2363-2369.
Crossref
Crossref
Kristin WalbergSamuel BaronJoyce PoastBarbara SchwartzLara IzotovaSidney PestkaJ.W. Peterson. (2008) Interferon Protects Mice Against Inhalation Anthrax. Journal of Interferon & Cytokine Research 28:10, pages 597-602.
Crossref
Crossref
J Kraus, K Voigt, AM Schuller, M Scholz, KS Kim, M Schilling, WR Schäbitz, P Oschmann & B Engelhardt. (2008) Interferon-β stabilizes barrier characteristics of the blood–brain barrier in four different species in vitro. Multiple Sclerosis Journal 14:6, pages 843-852.
Crossref
Crossref
Su-Hyung Park, Sang Rae Lee, Byung Hwa Hyun, Byong-Moon Kim & Young Chul Sung. (2008) Codelivery of PEG-IFN-α inhibits HCV DNA vaccine-induced T cell responses but not humoral responses in African green monkeys. Vaccine 26:32, pages 3978-3983.
Crossref
Crossref
Vito R. Cicinnati, Jinyu Kang, Georgios C. Sotiropoulos, Philip Hilgard, Andrea Frilling, Christoph E. Broelsch, Guido Gerken & Susanne Beckebaum. (2008) Altered chemotactic response of myeloid and plasmacytoid dendritic cells from patients with chronic hepatitis C: role of alpha interferon. Journal of General Virology 89:5, pages 1243-1253.
Crossref
Crossref
R.G. Thorne, L.R. Hanson, T.M. Ross, D. Tung & W.H. FreyIIII. (2008) Delivery of interferon-β to the monkey nervous system following intranasal administration. Neuroscience 152:3, pages 785-797.
Crossref
Crossref
N. Ceaglio, M. Etcheverrigaray, R. Kratje & M. Oggero. (2008) Novel long-lasting interferon alpha derivatives designed by glycoengineering. Biochimie 90:3, pages 437-449.
Crossref
Crossref
James E. Noble, Lili Wang, Eleonora Cerasoli, Alex E. Knight, Robert A. Porter, Elaine Gray, Chris Howe, Elisabeth Hannes, Philippe Corbisier, Jing Wang, Liqing Wu, Ilaria Altieri, Marina Patriarca, Angelika Hoffman, Ute Resch-Genger, Bernd Ebert, Jan Voigt, Yasushi Shigeri, Maxim S. Vonsky, Leonid A. Konopelko, Adolfas K. Gaigalas & Marc J.A. Bailey. (2008) An international comparability study to determine the sources of uncertainty associated with a non-competitive sandwich fluorescent ELISA. Clinical Chemistry and Laboratory Medicine 46:7.
Crossref
Crossref
Simona Malucchi & Antonio Bertolotto. 2008. Immunogenicity of Biopharmaceuticals. Immunogenicity of Biopharmaceuticals
27
56
.
Srikanta Dash, Sidhartha Hazari, Robert F Garry & Fredric Regenstein. 2008. Hepatitis C Virus Disease. Hepatitis C Virus Disease
16
38
.
O Cristina Micali, Herman H Cheung, Stéphanie Plenchette, Sandra L Hurley, Peter Liston, Eric C LaCasse & Robert G Korneluk. (2007) Silencing of the XAF1 gene by promoter hypermethylation in cancer cells and reactivation to TRAIL-sensitization by IFN-β. BMC Cancer 7:1.
Crossref
Crossref
Zahida Bhatti & Charles S Berenson. (2007) Adult systemic cat scratch disease associated with therapy for hepatitis C. BMC Infectious Diseases 7:1.
Crossref
Crossref
Patrizia Caposio, Francesca Gugliesi, Claudia Zannetti, Simone Sponza, Michele Mondini, Enzo Medico, John Hiscott, Howard A. Young, Giorgio Gribaudo, Marisa Gariglio & Santo Landolfo. (2007) A Novel Role of the Interferon-inducible Protein IFI16 as Inducer of Proinflammatory Molecules in Endothelial Cells. Journal of Biological Chemistry 282:46, pages 33515-33529.
Crossref
Crossref
Andrew W. HardyDavid R. Graham, Gene M. ShearerJean-Philippe Herbeuval. (2007) HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-α. Proceedings of the National Academy of Sciences 104:44, pages 17453-17458.
Crossref
Crossref
Norma Ibón Rallón, Vicente Soriano & José Miguel Benito. (2007) Respuesta inmunitaria celular adaptativa frente a la infección por el virus de la hepatitis C. Medicina Clínica 129:12, pages 469-476.
Crossref
Crossref
D. Hesse & P. S. Sørensen. (2007) Using measurements of neutralizing antibodies: the challenge of IFN-? therapy. European Journal of Neurology 14:8, pages 850-859.
Crossref
Crossref
Jean-Philippe Herbeuval & Gene M. Shearer. (2007) HIV-1 immunopathogenesis: How good interferon turns bad. Clinical Immunology 123:2, pages 121-128.
Crossref
Crossref
E. Peycheva, I. Daskalov & I. Tsoneva. (2007) Electrochemotherapy of Mycosis fungoides by interferon-α. Bioelectrochemistry 70:2, pages 283-286.
Crossref
Crossref
. (2007) My Career in Interferon and Host Defense Research. Journal of Interferon & Cytokine Research 27:4, pages 257-262.
Crossref
Crossref
Samuel BaronJessica HernandezJoseph BekiszJoyce PoastNeil GoldmanKathleen ClouseKaren FieldsSylvia BacotJiun WangKathryn Zoon. (2007)
Clinical Model: Interferons Activate Human Monocytes to An Eradicative Tumor Cell Level
In Vitro
. Journal of Interferon & Cytokine Research 27:2, pages 157-164.
Crossref
Crossref
Onder Ergonul, Ali Mirazimi & Dimiter S. Dimitrov. 2007. Crimean-Congo Hemorrhagic Fever. Crimean-Congo Hemorrhagic Fever
245
269
.
Hana SchmeisserPeter KontsekDominic EspositoWilliam GilletteGideon SchreiberKathryn C. Zoon. (2006)
Binding Characteristics of IFN-
α
Subvariants to IFNAR2-EC and Influence of the 6-Histidine Tag
. Journal of Interferon & Cytokine Research 26:12, pages 866-876.
Crossref
Crossref
C. Avendaño Solà. (2006) Interferones: tipos y acciones. Gastroenterología y Hepatología 29, pages 125-128.
Crossref
Crossref
Nicasio Mancini, Silvia Carletti, Mario Perotti, Luisa Romanò, Rosellina Di Stefano Craxì, Antonio Craxì, Alessandro R. Zanetti, Massimo Clementi & Roberto Burioni. (2006) Modulation of epitope‐specific anti‐hepatitis C virus E2 (anti‐HCV/E2) antibodies by anti‐viral treatment. Journal of Medical Virology 78:10, pages 1304-1311.
Crossref
Crossref
William Van Cleve, Emerito Amaro-Carambot, Sonja R. Surman, Joseph Bekisz, Peter L. Collins, Kathryn C. Zoon, Brian R. Murphy, Mario H. Skiadopoulos & Emmalene J. Bartlett. (2006) Attenuating mutations in the P/C gene of human parainfluenza virus type 1 (HPIV1) vaccine candidates abrogate the inhibition of both induction and signaling of type I interferon (IFN) by wild-type HPIV1. Virology 352:1, pages 61-73.
Crossref
Crossref
Jörg Kraus & Patrick Oschmann. (2006) The impact of interferon-β treatment on the blood–brain barrier. Drug Discovery Today 11:15-16, pages 755-762.
Crossref
Crossref
Josef Walker & David F. Tough. (2006) Modification of TLR‐induced activation of human dendritic cells by type I IFN: synergistic interaction with TLR4 but not TLR3 agonists. European Journal of Immunology 36:7, pages 1827-1836.
Crossref
Crossref
Jaroslaw Smieja, Mohammad Jamaluddin, Allan Brasier & Marek Kimmel. (2006) DETERMINISTIC MODELING OF INTERFERON-BETA SIGNALING PATHWAY. IFAC Proceedings Volumes 39:18, pages 423-428.
Crossref
Crossref
M.P. Green, L.D. Spate, J.A. Bixby, A.D. Ealy & R.M. Roberts. (2005) A Comparison of the Anti-Luteolytic Activities of Recombinant Ovine Interferon-Alpha and -Tau in Sheep1. Biology of Reproduction 73:6, pages 1087-1093.
Crossref
Crossref
Andrew R. Pachner, Donna Dail, Elena Pak & Kavitha Narayan. (2005) The importance of measuring IFNβ bioactivity: Monitoring in MS patients and the effect of anti-IFNβ antibodies. Journal of Neuroimmunology 166:1-2, pages 180-188.
Crossref
Crossref
Jordan J. Feld & Jay H. Hoofnagle. (2005) Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature 436:7053, pages 967-972.
Crossref
Crossref